Personal profile

Biographical details

Dr. Davide Danovi is leading the Cell Phenotyping Unit at King's College London in the framework of the HipSci project, funded by the Wellcome Trust and MRC.

Prior to this, he was principal scientist at Progenitor Labs, a novel biotechnology company founded to isolate drugs for regenerative medicine using innovative stem cell technologies.

Before, he worked with Prof. Austin Smith and Dr. Steve Pollard at the University of Cambridge and at University College London where he developed a live image based chemical screening platform to isolate compounds active on human neural stem cells from normal or brain tumour samples.

He holds an MD from University of Milan and a PhD in Molecular Oncology from the European Institute of Oncology where he demonstrated the causative role of the HdmX protein in human cancer.

Please click this link for a list of publications

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Doctor of Philosophy, European Institute of Oncology / Open University

Award Date: 1 Jan 2004

Doctor of Medicine, University of Milan

Award Date: 1 Jan 2000


  • Q Science (General)
  • stem cells
  • high content screening


Dive into the research topics where Davide Danovi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or